generations of glp 1 agonists GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1 agonists for weight loss:

S.et al (2022)

Liraglutide Can Reverse Memory Impairment, Synaptic Loss and Reduce Plaque Load in Aged APP/PS1 Mice, a Model of Alzheimers Disease

The study reported lower risks for several cancers, including hepatocellular, colorectal, breast, and prostate cancers, though it did not find a significant reduction in lung cancer risk.25 So the honest answer is this: current human evidence does not show that NAC causes cancer, but animal and mechanistic research suggests NAC could behave differently depending on cancer type, disease stage, dose, and treatment context

What is the significance of the Expression of Concern and retraction affecting Dihexa research

Renal impairment : L-carnitine is renally excreted, and accumulation may occur in kidney disease